Nestlé India and Dr. Reddy’s to form joint venture for health science nutraceutical portfolio

The JV Company will leverage the capabilities as well as services of the Nestlé Group and Dr. Reddy’s

Nestlé India and Dr Reddy’s Laboratories Ltd, both together referred to as “JV Partners”, announced that they have entered into a definitive agreement to form a joint venture (JV Company) to bring innovative nutraceutical brands to consumers in India and other agreed territories. The partnership will combine the well-known global range of nutritional health solutions, vitamins, minerals, herbs and supplements of Nestlé Health Science (NHSc) with the strong and established commercial strengths of Dr. Reddy’s in India. The joint venture will help JV Partners combine their strengths and grow their complementary nutraceutical portfolios in categories such as metabolic, hospital nutrition, general wellness, women’s health and child nutrition for consumers across India.

The JV Company will be headquartered in Hyderabad. The JV Company will leverage the capabilities as well as services of the Nestlé Group and Dr. Reddy’s.

Select brands will be licensed by the JV Partners to the JV company. The Nestlé Group will license brands such as Nature’s Bounty, Osteo Bi-Flex, Ester-C, Resource High Protein, Optifast, Resource Diabetic, Peptamen, Resource Renal and Resource Dialysis. Dr. Reddy’s will license brands such as Rebalanz, Celevida, Antoxid, Kidrich-D3, and Becozinc in the nutrition, and OTC segments. The JV Company is expected to become operational in Q2 of FY’25.